Mata P, Garrido JA, Ordovas JM, Blazquez E, Alvarez-Sala LA, Rubio MJ, Alonso R, de Oya M
Our Approach to Holding Drug Companies Responsible On October 6, 2023, Siskinds LLP filed a proposed GLP-1 drug class action in the Supreme Court of British Columbia against Novo Nordisk and affiliated entities on behalf of persons in Canada who were prescribed and used Ozempic, Rybelsus, and/or Wegovy and suffered serious injuries
If youre interested in using Ozempic for weight loss, which is an off-label use, talk with your doctor
If oral versions worked, they would change the market and create a need for peptide materials with new purity and stable requirements
Yeast was applied to GSH production to take advantage of its strong ability for ATP regeneration through the EMP pathway [13]
As of early 2026, retatrutide is not yet FDA approved